Local gene targeting and cell positioning using magnetic nanoparticles and magnetic tips: Comparison of mathematical simulations with experiments

Pharmaceutical Research

Volumn 29, Issue 5, 2012, Pages 1380-1391

  Kilgus, Carsten ^a   Heidsieck, Alexandra ^b   Ottersbach, Annika ^a   Roell, Wilhelm ^a   Trueck, Christina ^a   Fleischmann, Bernd K ^a   Gleich, Bernhard ^b   Sasse, Philipp ^a  

^a UNIVERSITY OF BONN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cell positioning; Gene targeting; Localization; Magnetic nanoparticles; Mathematical simulation

Indexed keywords

LENTIVIRUS VECTOR; MAGNETIC NANOPARTICLE;

ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL ASSAY; CELL TRANSPORT; CELLULAR DISTRIBUTION; COMPUTER SIMULATION; CONTROLLED STUDY; DENSITY GRADIENT; ELECTROPHYSIOLOGY; GENE EXPRESSION PROFILING; GENE TARGETING; GENE TRANSFER; HEART MUSCLE CELL; IN VITRO STUDY; INTERMETHOD COMPARISON; MAGNETIC FIELD; MATHEMATICAL MODEL; PREDICTION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TRANSPORT KINETICS;

ANIMALS; CELL LINE; CELLS, CULTURED; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; MAGNETICS; MODELS, THEORETICAL; MYOCYTES, CARDIAC; NANOPARTICLES;

EID: 84862686007     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0647-7     Document Type: Article

References (37)

1. Krishnan KM. Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Magn. 2010;46(7):2523-58.
2. Lübbe AS, Alexiou C, Bergemann C. Clinical applications of magnetic drug targeting. J Surg Res. 2001;95(2):200-6.
3. Alexiou C, Jurgons R, Schmid RJ, Bergemann C, Henke J, Erhardt W, et al. Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target. 2003;11 (3):139-49.
4. Ally J, Martin B, Khamesee MB, Roa W, Amirfazli A. Magnetic targeting of aerosol particles for cancer therapy. J Magn Magn Mater. 2005;293(1):442-9.
5. Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, Wiekhorst F, et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol. 2007;2(8):495-9.
6. Plank C, Schillinger U, Scherer F, Bergemann C, Remy JS, Krotz F, et al. The magnetofection method: using magnetic force to enhance gene delivery. Biol Chem. 2003;384(5):737-47.
7. Al-Deen FN, Ho J, Selomulya C, Ma C, Coppel R. Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine. Langmuir. 2011;27(7):3703-12.
8. Mykhaylyk O, Zelphati O, Rosenecker J, Plank C. siRNA delivery by magnetofection. Curr Opin Mol Ther. 2008;10(5):493-505.
9. Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Kruger A, et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 2002;9 (2):102-9.
10. Hofmann A, Wenzel D, Becher UM, Freitag DF, Klein AM, Eberbeck D, et al. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A. 2009;106(1):44-9.
11. Haim H, Steiner I, Panet A. Synchronized infection of cell cultures by magnetically controlled virus. J Virol. 2005;79(1):622-5.
12. Gleich B, Weyh T, Wolf B. Magnetic drug targeting: an analytical model for the influence of blood properties on particle trajectories. Applied Rheology 2008;18(5).
13. Babinec P, Krafcik A, Babincova M, Rosenecker J. Dynamics of magnetic particles in cylindrical Halbach array: implications for magnetic cell separation and drug targeting. Med Biol Eng Comput. 2010;48(8):745-53.
14. Krafcik A, Babinec P, Babincova M. Feasibility of subcutaneously implanted magnetic microarrays for site specific drug and gene targeting. J Eng Sci Tech Rev. 2010;3(1):53-7.
15. Gleich B, Hellwig N, Bridell H, Jurgons R, Seliger C, Alexiou C, et al. Design and evaluation of magnetic fields for nanoparticle drug targeting in cancer. IEEE Trans Nanotechnol. 2007;6(2):164-70.
16. Sharma MM, Chamoun H, Sarma DSHS, Schechter RS. Factors controlling the hydrodynamic detachment of particles from surfaces. J Colloid Interface Sci. 1992;149(1):121-34.
17. CornellU, SchwertmannU. The Iron Oxides.Weinheim,Germany: VCH Publishing Group; 1996.
18. Hafeli UO, Lobedann MA, Steingroewer J, Moore LR, Riffle J. Optical method for measurement of magnetophoretic mobility of individual magnetic microspheres in defined magnetic field. J Magn Magn Mater. 2005;293(1):224-39.
19. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, et al. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998;95(6):2979-84.
20. Trueck C, Zimmermann K, Mykhaylyk O, Anton M, Vosen S, Wenzel D, et al. Optimization of magnetic nanoparticles assistedlentiviral gene transfer. Pharm Res. 2011. doi:10.1007/s11095-011-0660-x.
21. Mykhaylyk O, Sanchez-Antequera Y, Vlaskou D, Hammerschmid E, Anton M, Zelphati O, et al. Liposomal magnetofection. Meth Mol Biol. 2010;605:487-525.
22. Mykhaylyk O, Sobisch T, Almstätter I, Sanchez-Antequera Y, Brandt S, Anton M, et al. Silica-iron oxide magnetic nanoparticles modified for gene delivery. A search for optimum and quantitative criteria. Pharm Res. 2011. doi:10.1007/s11095-011-0661-9.
23. Pfeifer A, Hofmann A. Lentiviral transgenesis. Meth Mol Biol. 2009;530:391-405.
24. Becher UM, Breitbach M, Sasse P, Garbe S, van der Ven PF, Furst DO, et al. Enrichment and terminal differentiation of striated muscle progenitors in vitro. Exp Cell Res. 2009;315(16):2741-51.
25. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007;110(4):1362-9.
26. Kolossov E, Bostani T, Roell W, Breitbach M, Pillekamp F, Nygren JM, et al. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med. 2006;203(10):2315-27.
27. Bruegmann T, Malan D, Hesse M, Beiert T, Fuegemann CJ, Fleischmann BK, et al. Optogenetic control of heart muscle in vitro and in vivo. Nat Methods. 2010;7(11):897-900.
28. Pislaru SV, Harbuzariu A, Gulati R, Witt T, Sandhu NP, Simari RD, et al. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol. 2006;48(9):1839-45.
29. Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation. 2005;112(20):3174-83.
30. Malan D, Friedrichs S, Fleischmann BK, Sasse P. Cardiomyocytes Obtained From Induced Pluripotent Stem Cells With Long-QT Syndrome 3 Recapitulate Typical Disease-Specific Features In Vitro. Circ Res 2011;109(8):841-7.
31. Weber W, Lienhart C, Baba MDE, Grass RN, Kohler T, Muller R, et al. Magnet-guided transduction of mammalian cells and mice using engineered magnetic lentiviral particles. J Biotechnol. 2009;141(3-4):118-22.
32. Furlani EJ, Furlani EP. A model for predicting magnetic targeting of multifunctional particles in the microvasculature. J Magn Magn Mater. 2007;312(1):187-93.
33. David AE, Cole AJ, Chertok B, Park YS, Yang VC. A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. J Control Release. 2011;152(1):67-75.
34. Shimizu K, Ito A, Lee JK, Yoshida T, Miwa K, Ishiguro H, et al. Construction of multi-layered cardiomyocyte sheets using magnetite nanoparticles and magnetic force. Biotechnol Bioeng. 2007;96 (4):803-9.
35. AkiyamaH, Ito A, Sato M, Kawabe Y, Kamihira M. Construction of cardiac tissue rings using a magnetic tissue fabrication technique. Int J Mol Sci. 2010;11(8):2910-20.
36. Chorny M, Fishbein I, Yellen BB, Alferiev IS, BakayM, Ganta S, et al. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proc Natl Acad Sci U S A. 2010;107(18):8346-51.
37. Riegler J, Wells JA, Kyrtatos PG, Price AN, Pankhurst QA, Lythgoe MF. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials. 2010; 31(20):5366-71.